Reference : Oral ibandronate (150mg) administered monthly provides similar improvements in hip bone ...
Scientific congresses and symposiums : Paper published in a journal
Human health sciences : General & internal medicine
Human health sciences : Rheumatology
http://hdl.handle.net/2268/82536
Oral ibandronate (150mg) administered monthly provides similar improvements in hip bone mineral density as oral alendronate (70mg) administered weekly in postmenopausal osteoporosis
English
Reginster, Jean-Yves mailto [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Borges, Joao LC [ > > ]
Recknor, Chris [ > > ]
Sedarati, Farhad [ > > ]
Neate, Colin [ > > ]
Cosman, Felicia [ > > ]
Sep-2007
Arthritis and Rheumatism
Wiley Liss, Inc.
56
number 9 (suppl.)
S611
Yes (verified by ORBi)
No
International
0004-3591
1529-0131
New York
NY
ACR/ARHP Annual Scientific Meeting 2007
du 6 novembre 2007 au 11 novembre 2007
American College of Rheumatology and Association of Rheumatology Health Professionals
Boston
USA
http://hdl.handle.net/2268/82536

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
1547.pdfPublisher postprint253.83 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.